AI Assistant
Blog
Pricing
Log In
Sign Up
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.